Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...
- The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...
For more information, please visit www.Trevena.com About TRV045 TRV045 is a novel, highly selective sphingosine-1-phosphate subtype 1 (S1P 1) receptor modulator being developed as a potential ...
FloCal?experts in pain relief?launch Bunnies Bum Crème to take the shame out soothing hemorrhoids, muscle soreness and skin conditions "As a Veteran of five deployments, we lacked accessible pain ...
Did you know, your feet can tell you a lot about your health? From pain to swelling, all kinds of illness symptoms can present in your extremities. Dr Amir Khan, a doctor in the UK, has shared five ...